<DOC>
	<DOCNO>NCT00841243</DOCNO>
	<brief_summary>Standard antiviral treatment consist weekly injection Peginterferon-α combination ribavirin . This treatment may lead significant weight loss ( 7 % within 24 week average ) , decrease quality life . In study investigator examine 50 patient whether nutritional advise support prevent weight loss antiviral therapy .</brief_summary>
	<brief_title>Nutritional Support During Antiviral Therapy Hepatitis C</brief_title>
	<detailed_description>Standard antiviral treatment consist weekly injection Peginterferon-α combination ribavirin . This therapy , however , lead weight loss approximately 7 % first 24 week therapy possibly relate impaired postprandial gastric empty . Such rapid weight loss marker deterioration nutritional status increase risk complication reduce immunological barrier function . Deterioration nutritional status also exacerbate side effect antiviral treatment like fatigue depression . As result , quality life patient may decrease . In current control , prospective , multicenter , study primarily aim compare effect preventative versus demand nutritional advice combination nutritional support reduction weight loss patient receive standard antiviral therapy PEG-interferon combination ribavirin . We randomize patient preventative intervention dietary consultation combine dietary supplementation daily snack demand dietary support group ( dietary follow , dietary advice snack , standard care ) . In demand group , patient refer dietitian case weight loss ≥ 5 % BMI &lt; 20 antiviral therapy . Assuming 60 % reduction weight loss first 24 week treatment clinically relevant , 2 x 25 patient need include ( α=0.05 , β=0.2 : power=0.8 drop-out rate 15 % ) . Primary aim ass whether intervention decrease amount weight loss therapy .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>Diagnosis hepatitis C Indication antiviral therapy Age &gt; 18 year Good understanding Dutch English language Informed consent Coinfection hepatitis B and/or HIV Significant non hepatic disease Significant previous surgery gastrointestinal tract Hepatocellular carcinoma current malignant disease BMI &lt; 20</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Antiviral therapy</keyword>
	<keyword>weight loss</keyword>
	<keyword>dietary support</keyword>
	<keyword>dietary advise</keyword>
</DOC>